Contribution of postprandial versus interprandial blood glucose to HbA(1c) in type 1 diabetes on physiologic intensive therapy with lispro insulin at mealtime

Diabetes Care

Volumn 22, Issue 5, 1999, Pages 795-800

  Ciofetta, Marco ^a   Lalli, Carlo ^a   Del Sindaco, Paola ^a   Torlone, Elisabetta ^a   Pampanelli, Simone ^a   Mauro, Lepore ^a   Chiara, Di Loreto ^a   Brunetti, Paolo ^a   Bolli, Geremia B ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GLYCOSYLATED HEMOGLOBIN; HUMAN INSULIN; INSULIN LISPRO; ISOPHANE INSULIN;

ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD GLUCOSE MONITORING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES CONTROL; DRUG EFFICACY; DRUG SAFETY; FEMALE; GLUCOSE ABSORPTION; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION;

ADULT; BLOOD GLUCOSE; CIRCADIAN RHYTHM; DIABETES MELLITUS, TYPE 1; DRUG ADMINISTRATION SCHEDULE; EATING; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; POSTPRANDIAL PERIOD;

EID: 0032925797     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.22.5.795     Document Type: Article

References (25)

1. Howey DC, Bowsher RR, Brunelle RL, WoodworthJR: [Lys(B28), Pro(B29)] human insulin: a rapidly absorbed analogue of human insulin. Diabetes 43:396-402, 1994
2. Bolli GB: Rapid-acting insulin analogs. Curr Opin Endocrinol Diabetes 4:277-281, 1997
3. Anderson JH, Brunelle R, Koivisto VA, Pfuetzner A, Trautman M, Vignati L, Di Marchi R, the Multicenter Insulin Lispro Study Group: Insulin analogue treatment reduces postprandial hyperglycemia and frequency of hypoglycemia in IDDM patients. Diabetes 46:265-270, 1997
4. Holleman F, Schmitt H, Rottiers R, Rees A, Symanowski S, Anderson J, the Benelux-U.K. Insulin Lispro Study Group: Reduced frequency of severe hypoglycemia and coma in well-controlled IDDM patients treated with insulin lispro. Diabetes Care 20:1827-1832, 1997
5. Brunelle RL, Llewelyn J, Anderson VA, Gale EAM, Koivisto VA: Meta-analysis of the effect of insulin lispro on severe hypoglycemia in patients with type 1 diabetes. Diabetes Care 21:1726-1731, 1998
6. Garg SK, Carmain JA, Braddy KC, Anderson JH, Vignati L, Jennings MK, Chase HP: Pre-meal insulin analogue insulin lispro versus Humulin R insulin treatment in young subjects with type 1 diabetes. Diabet Med 13:47-52, 1996
7. Pfuetzner A, Kuestner E, Forst T, Schulze-Schleppinghoff B, Tratuman M, Haslbeck M, Schatz H, Beyer J, the German Insulin Lispro/IDDM Study Group: Intensive insulin therapy with insulin lispro in patients with type 1 diabetes reduces the frequency of hypoglycemic episodes. Exp Clin Endocrinol 104:25-30, 1996
8. Rowe R, Anderson JH, Gale E: A double-blind comparison of insulin lispro and regular insulin in patients on a multiple injection regimen (Abstract). Diabetes 45 (Suppl. 2):71A, 1996
9. Jacobs MAJM, Keulen ETP, Kanc K, Casteleijn S, Scheffer P, Deville W, Heine RJ: Metabolic efficacy of preprandial administration of Lys(B28),Pro(B29) human insulin analog in IDDM patients. Diabetes Care 20:1279-1286, 1997
10. Heller SR, Amiel SA, Macdonald IA, Tattersail RB: Does insulin lispro preserve the physiological defenses to hypoglycaemia during intensive insulin therapy? (Abstract). Diabetologia 41 (Suppl. 1):A241, 1998
11. Nielsen FS, Jorgensen LN, Ipsen M, Voldsgaard AI, Parving HH: Long-term comparison of human insulin analogue BlOAsp and soluble human insulin in IDDM patients on a basal/bolus insulin regimen. Diabetologia 38:592-598, 1995
12. Torlone E, Pampanelli S, Lalli C, Del Sindaco P, Di Vincenzo A, Rambotti AM, Modarelli F, Epifano L, Kassi G, Perriello G, Brunetti P, Bolli GB: Effect of the short-acting insulin analog [LYS(B28),PRO(B29)] on postprandial blood glucose control in IDDM. Diabetes Care 19:945-952, 1996
13. Zinman B, Tildesley H, ChiassonJL, Tsui E, Strack TR: Insulin lispro in CSII: results of a double-blind crossover study. Diabetes 46:440-443, 1997
14. 1c and blood glucose stability in IDDM patients treated with lispro insulin analog in external pumps. Diabetes Care 21:977-982, 1998
15. Ebeling P, Jansson P-A, Smith U, Lalli C, Belli GB, Koivisto VA: Strategies toward improved control during insulin lispro therapy: importance of basal insulin. Diabetes Care 20:1287-1289, 1997
16. Del Sindaco P, Ciofetta M, Lalli C, Perriello G, Pampanelli S, Torlone E, Brunetti P, Bolli GB: Use of short-acting insulin analogue lispro in intensive treatment of type 1 diabetes mellitus: importance of appropriate replacement of basal insulin and time-interval injection-meal. Diabet Med 15:592-600, 1998
17. Jansson P-A, Ebeling P, Smith U, Conget I, Coves MJ, Gomis R, Lalli C, Del Sindaco P, Bolli GB, Koivisto VA: Improved glycemic control can be better maintained with insulin lispro than with human regular insulin. Diabetes Nutr Metab 11:194-199, 1998
18. Lalli C, Ciofetta M, Del Sindaco P, Torlone E, Pampanelli S, Compagnucci P, Cartechini MG, Bartocci L, Brunetti P, Bolli GB: Long-term intensive treatment of type 1 diabetes with the short-acting insulin analog lispro in variable combination with NPH insulin at mealtime. Diabetes Care 22:468-477, 1999
19. Colombel A, Murat A, Anton B, Krempf M, Charbonnel B: A multiple daily injection regimen using lispro and multiple NPH insulins compared to regular insulin: a randomized crossover study Diabet Med. (In press)
20. 1c, risk for severe and mild hypoglycaemia, status of counterregulation and unawareness of hypoglycaemia. Diabetologia 39: 677-686, 1996
21. Perriello G., Torlone E, Di Santo S, Fanelli C, De Feo P, Santeusanio F, Brunetti P, Bolli GB: Effects of storage temperature of insulin on pharmacokinetics and pharmacodynamics of insulin mixtures injected subcutaneously in subjects with IDDM. Diabetologia 31:811-815, 1988
22. Zar J: Biostatistical analysis. Englewood Cliffs, Prentice Hall, 1984
23. Ahmed ABE, Home PD: The effect of the insulin analog lispro on nighttime blood glucose control in type 1 diabetic patients. Diabetes Care 21:32-37, 1998
24. Bolli GB, Perriello G, Fanelli C, De Feo P: Nocturnal blood glucose control in type 1 diabetes mellitus. Diabetes Care 16 (Suppl. 3):71-89, 1993
25. Pieber TR, Eugene-Jolchine I, Derobert E: Efficacy and safety of HOE 901 in patients with type 1 diabetes: a four week randomised, NPH insulin-controlled trial (Abstract). Diabetologia 41 (Suppl. 1):A49, 1998